Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Castle Technologies, Inc. (NASDAQ: CSTL) | Delayed: 35.75 +0.61 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.14 | 52 Week High | $3.92 | |||
| Open | $36.03 | 52 Week Low | $0.00 | |||
| Day High | $36.43 | P/E | N/A | |||
| Day Low | $35.07 | EPS | $0.00 | |||
| Volume | 462,476 | |||||
